Episode Details
Back to EpisodesWeekly Headlines: Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations
Published 1 year, 9 months ago
Description
Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations • Ultrasonic Sensor Device Launched for Loss of Side Vision • Ocuvex Therapeutics Acquires Visiox Pharmaceuticals
Learn more about your ad choices. Visit megaphone.fm/adchoices